What properties, at the level of individual molecules, are responsible for allowing the adaptive immune system to differentiate cancerous cells from surrounding healthy tissue? This question is the bedrock of tumor immunology, for without some method of differentiation it would be impossible for immunity to recognize and kill tumor cells without simultaneously damaging normal organ systems. The primary hypothesis underlying this document is that an improved ability to measure and monitor antigen-specific adaptive immunity will lead to improved outcomes for patients with cancer.